AU6074699A - Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy - Google Patents

Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy

Info

Publication number
AU6074699A
AU6074699A AU60746/99A AU6074699A AU6074699A AU 6074699 A AU6074699 A AU 6074699A AU 60746/99 A AU60746/99 A AU 60746/99A AU 6074699 A AU6074699 A AU 6074699A AU 6074699 A AU6074699 A AU 6074699A
Authority
AU
Australia
Prior art keywords
glutathione
arsenic
modulators
antimony
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60746/99A
Inventor
Gerald Batist
Kelly Davison
Wilson Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU6074699A publication Critical patent/AU6074699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
AU60746/99A 1998-10-13 1999-10-12 Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy Abandoned AU6074699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2250631 1998-10-13
CA2250631 1998-10-13
PCT/CA1999/000949 WO2000021506A2 (en) 1998-10-13 1999-10-12 Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy

Publications (1)

Publication Number Publication Date
AU6074699A true AU6074699A (en) 2000-05-01

Family

ID=4162919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60746/99A Abandoned AU6074699A (en) 1998-10-13 1999-10-12 Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy

Country Status (2)

Country Link
AU (1) AU6074699A (en)
WO (1) WO2000021506A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002226382A (en) * 2001-01-31 2002-08-14 Gifu International Institute Of Biotechnology Therapeutic agent for cancer
EP1401426B1 (en) * 2001-05-31 2008-07-23 The Cleveland Clinic Foundation Ptpase inhibitors and method of using same
US7416723B2 (en) 2001-09-07 2008-08-26 The Cleveland Clinic Foundation Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
US20100009928A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
LT2574341T (en) 2004-03-29 2017-09-11 University Of South Florida Effective treatment of tumors and cancer with triciribine phosphate
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935450A (en) * 1982-09-17 1990-06-19 Therapeutical Systems Corporation Cancer therapy system for effecting oncolysis of malignant neoplasms
US5877185A (en) * 1991-10-22 1999-03-02 Octamer, Inc. Synergistic compositions useful as anti-tumor agents
US6057367A (en) * 1996-08-30 2000-05-02 Duke University Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses

Also Published As

Publication number Publication date
WO2000021506A3 (en) 2000-07-20
WO2000021506A2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
AU8127998A (en) Quinoline compounds and medicinal uses thereof
AU4818099A (en) Phosphodiesterase-v modulator drugs and their uses
AU5984296A (en) Quinazolines and pharmaceutical compositions
AU2212299A (en) Compositions and methods for the treatment of tumor
AU1157599A (en) Pyrimidinone compounds and pharmaceutical compositions containing them
AU6740298A (en) Pharmaceutical composition
AU1623300A (en) Monodisperse preparations useful with implanted devices
AU1545495A (en) Therapeutic composition for replacing and/or supplementing body fluids
ZA989885B (en) Use of macrolides for the treatment of cancer and macular degeneration
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU6074699A (en) Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy
AU1502799A (en) Pharmaceutical composition comprising clioquinol and vitamin B12
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5333298A (en) Compositions and methods for tumour therapy
AU9343098A (en) Pharmaceutical composition
AU1782600A (en) Melatonin derivatives and medicine containing same
AU1172097A (en) Pharmaceutical composition containing trehalose
AU732214C (en) Biphenyl derivatives and drug composition
AU2513899A (en) Mixture and pharmaceutical composition comprising z-4-hydroxytamoxifen and cyclodextrin
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AU6875096A (en) Pharmaceutical composition with trypanocidal properties
AU7681498A (en) Pharmaceutical composition and use thereof
AU8968598A (en) Bovine footrot treatment and prevention
AU2566799A (en) Chemical derivatives of autoantigens and autoimmune-suppressive peptides and pharmaceutical composition containing the same
AU1464399A (en) Reagent for tumor therapy and/or imaging

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase